Classification of variant forms of haemoglobin according to the ratio of glycated haemoglobin to glycated albumin

Annals of Clinical Biochemistry

Volumn 49, Issue 5, 2012, Pages 441-444

  Miyazaki, Ayako ^a   Kohzuma, Takuji ^b   Kasayama, Soji ^c   Koga, Masafumi ^d  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b ASAHI KASEI PHARMA CORPORATION   (Japan)

^c NISSAY HOSPITAL   (Japan)

^d Kinki Central Hospital of Mutual Association of Public School Teachers   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED ALBUMIN; HEMOGLOBIN A1C; HEMOGLOBIN ALPHA CHAIN; HEMOGLOBIN BETA CHAIN; HEMOGLOBIN HIMEJI; HEMOGLOBIN I INTERLAKEN; HEMOGLOBIN J MEERUT; HEMOGLOBIN PETERBOROUGH; HEMOGLOBIN VARIANT; HEMOGLOBIN WOOLWICH; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; DIABETIC PATIENT; DNA DETERMINATION; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOASSAY; MASS SPECTROMETRY; PRIORITY JOURNAL;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; GENETIC VARIATION; HEMOGLOBIN A, GLYCOSYLATED; HEMOGLOBINS; HUMANS; IMMUNOASSAY; REFERENCE STANDARDS; SERUM ALBUMIN; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 84867179213     PISSN: 00045632     EISSN: 17581001     Source Type: Journal    
DOI: 10.1258/acb.2012.011192     Document Type: Article

References (22)

1. Wajcman H. Human Hemoglobin Variants, the Electric Versions. See http://globin.cse.psu.edu (last checked 20 December 2011)
2. Bry L, Chen PC, Sacks DB. Effects of hemoglobin variants and chemically modified derivatives on assays for glycohemoglobin. Clin Chem 2001;47:153-63
3. 1c determination methods in patients with hemoglobinopathies. Diabetes Care 2000;23:339-44
4. Thomas LB, Agosti SJ, Man MA, Mastorides SM. Screening for hemoglobinopathies during routine hemoglobin A1c testing using the Tosoh G7 Glycohemoglobin Analyzer. Ann Clin Lab Sci 2007;37:251-5
5. Halwachs-Baumann G, Katzensteiner S, Schnedl W, Pürstner P, Pieber T, Wilders-Truschnig M. Comparative evaluation of three assay systems for automated determination of hemoglobin A1c. Clin Chem 1997;43:511-7
6. Shimizu A, Nakanishi T, Miyazaki A. Detection and characterization of variant and modified structures of proteins in blood and tissues by mass spectrometry. Mass Spectrom Rev 2006;25:686-712
7. Koga M, Kasayama S. Clinical impact of glycated albumin as another glycemic control marker. Endocr J 2010;57:751-62
8. Koga M, Otsuki M, Matsumoto S, Saito H, Mukai M, Kasayama S. Negative association of obesity and its related chronic inflammation with serum glycated albumin but not glycated hemoglobin levels. Clin Chim Acta 2007;378:48-52
9. Bando Y, Kanehara H, Kasayama S, Koga M. Association of serum glycated albumin to glycated haemoglobin A1C ratio with hepatic function tests in patients with chronic liver disease. Ann Clin Biochem 2009;46:368-72
10. 1c measurements by electrospray ionization mass spectrometry. Clin Chim Acta 2002;323:89-101
11. The Committee of Japan Diabetes Society on the diagnostic criteria of diabetes mellitus. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. J Diabetes Invest 2010;1:212-28
12. Shima K, Ito N, Abe F, Hirota M, et al. High-performance liquid chromatographic assay of serum glycated albumin. Diabetologia 1988;31:627-31
13. Harano K, Harano T, Shibata S, et al. Hb J Oxford [alpha 15 (A13) Gly→Asp] in Japan. Hemoglobin 1984;8:197-8
14. Schiliro G, Rizzari C, Testa R, Lo Faro F, Comisi FF, Russo A. Association of Hb S [beta 6(A3)Glu--Val] and Hb I-interlaken [alpha 15(A13)Gly--Asp] in a Sicilian man; review of the occurrence of Hb I-interlaken in Sicily. Hemoglobin 1989;13:403-10
15. Blackwell RQ, Wong HB, Wang CL, Weng MI, Liu CS. Hemoglobin J Meerut: alpha120 Ala leads to Glu. Biochim Biophys Acta 1974;351:7-12
16. Ringelhann B, Konotey-Ahulu FI, Talapatra NC, Nkrumah FK, Wiltshire BG, Lehmann H. Haemoglobin K. Woolwich (alpha 2, beta 2 132 lysine leads to glutamine) in Ghana. Acta Haematol 1971;45:250-8
17. Ohba Y, Miyaji T, Murakami M, et al. Hb Himeji or beta 140 (H18) Ala→Asp. A slightly unstable hemoglobin with increased beta N-terminal glycation. Hemoglobin 1986;10:109-25
18. Nishihara E, Koga M, Kadowaki S, et al. Method-dependent HbA1c values in a family with hemoglobin Himeji. Clin Chim Acta 2011;412:1689-92
19. Nakanishi T, Miyazaki A, Kishikawa M, Shimizu A, Aoki Y, Kikuchi M. Hb Peterborough [beta 111(G13)Val→Phe] in Japan; rapid identification by ESI/MS using proteolytic digests of oxidized globin. Hemoglobin 1998;22:23-35
20. Armbruster DA. Fructosamine: structure, analysis, and clinical usefulness. Clin Chem 1987;33:2153-63
21. Jeffcoate SL. Diabetes control and complications: the role of glycated haemoglobin, 25 years on. Diabet Med 2004;21:657-65
22. Coban E, Ozdogan M, Timuragaoglu A. Effect of iron deficiency anemia on the levels of hemoglobin A1c in nondiabetic patients. Acta Haematol 2004;112:126-8